Developing therapeutic platforms from new biological insight

ClearMTB Therapeutics is a Danish research-driven biotechnology company developing therapeutic platforms across side-effect therapeutics, cell engineering and microbiome-based medicine.

Odense & Assens, Fyn — Denmark · Founded 2024
Our model

Platform-based research

We operate through a platform-based research model in which biological mechanisms are formalized as therapeutic frameworks. These frameworks can subsequently be translated into concrete treatment programs or strategic partnerships with larger biotechnology and pharmaceutical companies.

Our goal is to identify underexplored biological opportunities and develop them into structured therapeutic platforms capable of supporting translational research and future clinical development.

Approach

Three domains of innovation

Our research focuses on three primary scientific areas that together form the foundation of our therapeutic development strategy.

01

Side-Effect Therapeutics

Side-Effect Therapeutics focuses on the biological mechanisms that drive treatment-limiting adverse effects, developing adjunct therapeutic strategies that can be used alongside existing and emerging drug classes. By addressing these mechanisms directly, such approaches enable more patients to start therapy, remain on treatment longer, and benefit more fully from modern medicines.

02

Cell Engineering

Developing biological and computational frameworks to improve the stability, persistence and functional reliability of engineered cellular systems. This work focuses on understanding how cellular systems can be designed for long-term stability and therapeutic performance.

03

Engineered Microbiome Therapeutics

Designing microbiome-based therapeutic systems capable of coordinated modulation of multiple biological pathways within the gastrointestinal system. These approaches aim to leverage the complexity of microbial ecosystems to influence host biology in a controlled therapeutic manner.

Pipeline

Our therapeutic platforms

ClearMTB Therapeutics develops research platforms across three primary therapeutic domains.

PlatformDescription
Side-Effect Therapeutics
Development of treatment-enabling therapeutics designed to mitigate treatment-limiting adverse effects in existing and emerging drug classes, improving tolerability and enabling broader clinical use.
Cell Engineering
Biological and computational frameworks designed to improve stability, persistence and long-term functional performance in engineered cellular systems.
Engineered Microbiome Therapeutics
Development of engineered microbiome systems capable of coordinated modulation of biological pathways within complex physiological environments.
New biological mechanisms, translated into therapeutic platforms
— ClearMTB Therapeutics research philosophy
Team

Research-focused leadership

A small, dedicated team driving ClearMTB's therapeutic platforms forward from Fyn, Denmark.

MM

Mathias Madsen

CEO & Founder

NH

Noah Hansen

VP Communications & Outreach

NL

Noah Laursen

Research Director

VP

Victor Peter

Research Associate

Collaboration

Open for partnerships

We seek collaboration with organizations that share our ambition to develop the next generation of therapeutic platforms.

Academic institutions

Joint research projects and knowledge exchange within our platform domains. We actively seek academic partnerships to strengthen the scientific foundation of our frameworks.

Biotech companies

Strategic partnerships for development and validation of new therapeutic frameworks. We are designed to work with partners who can bring these platforms through clinical development.

Translational organizations

Translating research findings into clinically relevant programs and treatments. We bridge the gap between biological insight and therapeutic application.

Contact

Get in touch

Location

Odense & Assens
Fyn, Denmark

Interested in working with us?

We are always open to discuss collaboration opportunities with research institutions, biotech companies and translational organizations. We look forward to hearing from you.

Send us an email